Rare, deadly skin condition under the microscope: french study sheds light on calciphylaxis
NCT ID NCT02854046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked back at 80 French patients with calciphylaxis, a rare and often fatal condition causing painful skin ulcers, mostly in people with severe kidney disease. Researchers aimed to describe patient characteristics, how doctors diagnose and treat the condition, and what factors affect survival. No new treatment was tested; instead, the goal was to gather knowledge to guide future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CALCIPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nantes
Nantes, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could an arthritis drug stop a deadly skin condition?
- New hope for rare, painful skin disease: experimental drug EPN-701 enters phase 2 trial
- New study aims to crack the code of deadly skin hardening in kidney patients
- Amniotic stem cells tested for rare, painful skin condition in kidney patients
- Oxygen chamber therapy put to the test for dozens of diseases